Side effects of Mounjaro: what to expect
Side effects of Mounjaro can include nausea, diarrhea, and vomiting. Know which symptoms are common, which are serious, and when to call.
Key facts
- Tirzepatide + B12 is $169/month (billed $169 every 4 weeks), charged only after a clinician approves it.
- Answer a few health questions online. A licensed clinician reviews them. If approved, it ships to your door.
- Adults 18 or older. A licensed clinician reviews your health history and decides whether treatment is appropriate for you. Availability depends on the state you live in.
Side effects of Mounjaro (tirzepatide) range from mild digestive symptoms to rare but serious problems that need prompt medical care. Knowing which symptoms are expected versus concerning can help you act quickly and avoid complications. This guide summarizes what the FDA label and Medication Guide report, plus what to discuss with your clinician. Vitals Vault also includes lab options and PocketMD to help you organize symptoms and questions for a clinician visit.
- Side effects of Mounjaro are often digestive, but some symptoms need urgent evaluation.
- Nausea, diarrhea, vomiting, constipation, and stomach pain are among the most common effects.
- Seek urgent care for severe belly pain, dehydration, allergic symptoms, or signs of low blood sugar.
- Mounjaro has a boxed warning about thyroid C-cell tumors; avoid it with certain thyroid cancer histories.
Quick answer
Most are digestive
The most common side effects of Mounjaro are nausea, diarrhea, vomiting, constipation, and stomach pain. These are reported most often when starting or increasing the dose and may improve over time. If symptoms are persistent or severe, contact your prescribing clinician.
Some symptoms are urgent
Severe abdominal pain (especially with vomiting), symptoms of dehydration, or signs of an allergic reaction can signal a serious problem. Mounjaro can also cause low blood sugar when used with insulin or sulfonylureas, which may require prompt treatment. Do not wait for a routine follow up if you feel very unwell.
Boxed warning applies
Mounjaro carries a boxed warning about thyroid C-cell tumors seen in rodents. It is contraindicated if you have a personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2). Discuss any thyroid nodules, hoarseness, trouble swallowing, or neck swelling with a clinician.
Common and serious side effects
Nausea
Nausea is one of the most commonly reported side effects with tirzepatide. It is often related to slower stomach emptying and may be more noticeable after dose increases. If you cannot keep fluids down or you have signs of dehydration, contact a clinician promptly.
Diarrhea or constipation
Changes in bowel habits, including diarrhea and constipation, are common with Mounjaro. Staying hydrated matters because ongoing diarrhea or vomiting can contribute to kidney problems. Tell your clinician if symptoms are severe, persistent, or accompanied by dizziness or fainting.
Vomiting
Vomiting can occur, especially early in treatment or after dose escalation. Repeated vomiting raises the risk of dehydration and may worsen kidney function in susceptible people. Seek care if vomiting is persistent, you cannot keep liquids down, or you develop severe abdominal pain.
Stomach pain
Abdominal pain can be a common side effect, but severe and persistent pain is not something to ignore. Severe abdominal pain that may radiate to the back, with or without vomiting, can be a warning sign of pancreatitis. Contact urgent care or emergency services if pain is severe or rapidly worsening.
Pancreatitis
Acute pancreatitis has been reported with GLP-1 receptor agonists, including tirzepatide. The label advises stopping tirzepatide if pancreatitis is suspected and not restarting if confirmed, which is a decision for a clinician. Severe abdominal pain with vomiting is a classic reason to seek urgent evaluation.
Gallbladder problems
Gallbladder disease, including cholelithiasis (gallstones) and cholecystitis (gallbladder inflammation), has been reported with tirzepatide. Symptoms can include right upper abdominal pain, fever, nausea, vomiting, or yellowing of the skin or eyes. Prompt evaluation is important because complications can occur.
Kidney problems from dehydration
The label warns that gastrointestinal side effects such as nausea, vomiting, and diarrhea can lead to dehydration, which may worsen kidney function. This risk can be higher if you already have kidney disease or are taking medicines that affect hydration. Contact a clinician if you have reduced urination, dizziness, or inability to keep fluids down.
Low blood sugar with some drugs
Tirzepatide can increase the risk of hypoglycemia (low blood sugar) when used with insulin or insulin secretagogues such as sulfonylureas. Symptoms can include sweating, shakiness, fast heartbeat, confusion, or fainting. Your clinician may adjust other diabetes medicines to reduce risk.
Allergic reactions
Serious hypersensitivity reactions, including anaphylaxis and angioedema, have been reported with tirzepatide. Seek emergency care for trouble breathing, swelling of the face or throat, or widespread rash. Tell your clinician about any prior reactions to medicines in this class.
Diabetic retinopathy changes
Rapid improvement in blood sugar can temporarily worsen diabetic retinopathy in some people with diabetes. If you have diabetes and notice vision changes, contact your eye clinician or prescribing clinician. This is especially important if you already have retinopathy.
Injection-site reactions
Injection site reactions can occur, such as redness or itching where the medicine was injected. These are usually mild, but report severe or persistent reactions to your clinician. If you have signs of a systemic allergic reaction, seek urgent care.
Hair loss and fatigue
Some people report hair shedding or fatigue while using GLP-1 medicines. These symptoms can have multiple causes, including reduced calorie intake, rapid weight change, stress, or nutrient issues. If it is new, persistent, or concerning, discuss it with a clinician rather than assuming it is from the medication.
How long do side effects usually last?
Often early or after increases
Digestive side effects are commonly reported when starting tirzepatide and after dose escalation. Many people find these effects lessen as the body adjusts, but some symptoms can persist. If symptoms are not improving or are affecting hydration and nutrition, contact your clinician.
Persistent severe symptoms
Severe abdominal pain, repeated vomiting, fainting, or allergic symptoms are not expected adjustment effects. These can indicate pancreatitis, gallbladder disease, dehydration-related kidney problems, or hypersensitivity reactions. Seek urgent evaluation rather than waiting for symptoms to pass.
Longer-term monitoring
Some risks relate to ongoing treatment, such as gallbladder disease or changes in blood sugar that can affect eye disease in people with diabetes. Your clinician may monitor symptoms, other medications, and relevant health conditions over time. Bring new symptoms up early so they can be evaluated.
When to call a clinician or seek urgent care
Seek urgent care now
Get urgent evaluation for severe or worsening abdominal pain, especially with vomiting; signs of dehydration (fainting, confusion, very low urination); trouble breathing or swelling of the face or throat; or severe low blood sugar symptoms such as confusion or passing out. These can signal pancreatitis, kidney injury from dehydration, or a serious allergic reaction. If you are unsure, err on the side of urgent care.
Call your prescriber soon
Contact your prescribing clinician if nausea, diarrhea, constipation, or vomiting is persistent, prevents normal eating and drinking, or is getting worse after dose changes. Also call if you develop new vision changes (especially if you have diabetes), ongoing stomach pain, or symptoms that interfere with daily activities. Your clinician can assess whether the symptom is medication-related or needs a different workup.
Before starting or restarting
Discuss your history of pancreatitis, gallbladder disease, kidney disease, severe gastrointestinal disease, or diabetic retinopathy. Tell your clinician about all diabetes medicines, especially insulin or sulfonylureas, because of hypoglycemia risk. Mounjaro is contraindicated with a personal or family history of MTC or MEN 2.
Frequently Asked Questions
What are the side effects of Mounjaro?
The most common side effects reported with Mounjaro (tirzepatide) are gastrointestinal, including nausea, diarrhea, vomiting, constipation, and abdominal pain. More serious risks include pancreatitis, gallbladder disease, dehydration-related kidney problems, allergic reactions, and low blood sugar when used with certain diabetes medicines.
Are side effects of Mounjaro different at 7.5 mg or 10 mg?
The FDA label reports that gastrointestinal side effects are common with tirzepatide and can be more noticeable when starting or increasing the dose. Individual tolerance varies, and some people have more symptoms after dose escalation. If symptoms are severe or persistent, contact your prescribing clinician.
Mounjaro vs Ozempic side effects: are they similar?
They are often similar because both medicines can slow stomach emptying and commonly cause nausea, vomiting, diarrhea, constipation, and abdominal pain. Both also carry warnings about pancreatitis and gallbladder disease. Differences in how often a side effect occurs depend on the specific drug and study population.
Can Mounjaro cause cancer?
Mounjaro has a boxed warning about thyroid C-cell tumors seen in rodents, and it is contraindicated in people with a personal or family history of medullary thyroid carcinoma (MTC) or MEN 2. It is not known if tirzepatide causes thyroid C-cell tumors in humans. Discuss thyroid symptoms such as a neck lump, hoarseness, or trouble swallowing with a clinician.
What should I do if I have Mounjaro stomach pain?
Mild stomach discomfort can happen, but severe or persistent abdominal pain needs medical evaluation. Severe pain, especially with vomiting, can be a warning sign of pancreatitis or gallbladder disease. If symptoms are severe or rapidly worsening, seek urgent care.